Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8)

Karacin C.Oksuzoglu B.Demirci A.Keskinkılıç M.Baytemür N.K.Yılmaz F.Selvi O.Erdem D.Avşar E.Paksoy N.Demir N.Göksu S.S.Türker S.Bayram E.Çelebi A.Yılmaz H.Kuzu Ö.F.Kahraman S.Gökmen İ.Sakin A.Alkan A.Nayır E.Uğraklı M.Acar Ö.Ertürk İ.Demir H.Aslan F.Sönmez Ö.Korkmaz T.Celayir Ö.M.Karadağ İ.Kayıkçıoğlu E.Şakalar T.Öktem İ.N.Eren T.Erul E.Mocan E.E.Kalkan Z.Yıldırım N.Ergün Y.Akagündüz B.Karakaya S.Kut E.Teker F.Demirel B.Ç.Karaboyun K.Almuradova E.Ünal O.Ü.Oyman A.Işık D.Okutur K.Öztosun B.Gülbağcı B.B.Kalender M.E.Şahin E.Seyyar M.Özdemir Ö.Selçukbiricik F.Kanıtez M.Dede İ.Gümüş M.Gökmen E.Yaren A.Menekşe S.Ebinç S.Aksoy S.İmamoğlu G.İ.Altınbaş M.Çetin B.Uluç B.O.Er Ö.Karadurmuş N.Erdoğan A.P.Artaç M.Tanrıverdi Ö.Çiçin İ.Şendur M.A.N.Oktay E.Bayoğlu İ.V.Paydaş S.Aydıner A.Salim D.K.Geredeli Ç.Yavuzşen T.Doğan M.Hacıbekiroğlu İ.2025-04-102025-04-102023http://hdl.handle.net/20.500.14701/44567Following publication of the original article [1], the authors reported an error in the author name of Enes Erul. Incorrect: Enes Urul Correct: Enes Erul, The original article [1] has been corrected. © 2023, The Author(s).Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8)Erratum10.1186/s12885-023-10662-3